|
IL130223A
(en)
|
1996-12-19 |
2005-09-25 |
Aventis Pharma Inc |
Heterocyclic substituted pyrrolidine amide derivatives, process for their preparation and pharmaceutical compositions containing them
|
|
ATE264337T1
(de)
|
1999-08-31 |
2004-04-15 |
Kissei Pharmaceutical |
Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
|
|
MXPA02003254A
(es)
|
1999-09-27 |
2002-09-30 |
Pioneer Hi Bred Int |
Tolerancia mejorada al estres en maiz via manipulacion de los genes reguladores del ciclo de la celula.
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
AU2002223127A1
(en)
|
2000-11-30 |
2002-06-11 |
Kissei Pharmaceutical Co., Ltd. Intellectual Property |
Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
|
PL209375B1
(pl)
|
2000-12-28 |
2011-08-31 |
Kissei Pharmaceutical |
Pochodne glukopiranozyloksypirazolu, kompozycja farmaceutyczna zawierająca takie pochodne i zastosowanie tych pochodnych do wytwarzania kompozycji farmaceutycznej
|
|
JP4490109B2
(ja)
|
2002-03-22 |
2010-06-23 |
キッセイ薬品工業株式会社 |
グルコピラノシルオキシベンジルベンゼン誘導体の結晶
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
ATE443044T1
(de)
|
2002-12-19 |
2009-10-15 |
Vertex Pharma |
Tace inhibitoren
|
|
JP2006518381A
(ja)
|
2003-02-07 |
2006-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール
|
|
ES2567571T3
(es)
|
2003-03-14 |
2016-04-25 |
Astellas Pharma Inc. |
Derivados de C-glucósido y sales de los mismos
|
|
LT2896397T
(lt)
|
2003-08-01 |
2017-11-27 |
Mitsubishi Tanabe Pharma Corporation |
Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
ATE557013T1
(de)
|
2004-03-16 |
2012-05-15 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
CA2579889A1
(en)
|
2004-09-09 |
2006-03-16 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 inhibitory activity
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
BRPI0617162B8
(pt)
|
2005-10-07 |
2021-05-25 |
Exelixis Inc |
compostos inibidores de fosfatidilinositol 3-quinase composições farmacêuticas que os contem e métodos de uso dos mesmos
|
|
WO2007093610A1
(en)
|
2006-02-15 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
|
WO2007120528A2
(en)
|
2006-03-31 |
2007-10-25 |
La Jolla Pharmaceutical Company |
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
|
|
JP5230613B2
(ja)
|
2006-05-23 |
2013-07-10 |
テラコス・インコーポレイテッド |
グルコース輸送体阻害剤およびその使用方法
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
TW200831485A
(en)
|
2006-12-11 |
2008-08-01 |
Boehringer Ingelheim Int |
New pyridazine derivatives with MCH antagonistic activity and medicaments comprising these compounds
|
|
AR065809A1
(es)
|
2007-03-22 |
2009-07-01 |
Bristol Myers Squibb Co |
Formulaciones farmaceuticas que contienen un inhibidor sglt2
|
|
AU2008279424B2
(en)
|
2007-07-26 |
2013-06-13 |
Lexicon Pharmaceuticals, Inc. |
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
|
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
MX2010002695A
(es)
|
2007-09-10 |
2010-04-01 |
Janssen Pharmaceutica Nv |
Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
|
|
TW201011043A
(en)
|
2008-06-20 |
2010-03-16 |
Chugai Pharmaceutical Co Ltd |
Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
|
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
|
|
EP2419097B1
(en)
|
2009-04-16 |
2013-09-25 |
Taisho Pharmaceutical Co., Ltd. |
Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes
|
|
JP5640983B2
(ja)
*
|
2009-09-16 |
2014-12-17 |
アステラス製薬株式会社 |
グリシン化合物
|
|
AU2010303123B2
(en)
|
2009-09-30 |
2014-02-27 |
Boehringer Ingelheim International Gmbh |
Method for the preparation of a crystalline form of 1-chloro-4- (Beta-D-glucopyranos-1-yl)-2-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)benzene
|
|
JP5758900B2
(ja)
|
2009-09-30 |
2015-08-05 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換ベンジルベンゼン誘導体の調製方法
|
|
FI20115234A0
(fi)
|
2011-03-08 |
2011-03-08 |
Biotie Therapies Corp |
Uusia pyridatsinoni- ja pyridoniyhdisteitä
|
|
SG193307A1
(en)
|
2011-03-15 |
2013-10-30 |
Astellas Pharma Inc |
Guanidine compound
|
|
EP3438087A1
(en)
|
2012-05-02 |
2019-02-06 |
Boehringer Ingelheim International GmbH |
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
|
CA2960280A1
(en)
|
2014-09-10 |
2016-03-17 |
Epizyme, Inc. |
Substituted piperidine compounds
|
|
US10759781B2
(en)
|
2015-08-06 |
2020-09-01 |
Ube Industries, Ltd. |
Substituted guanidine derivatives
|
|
EP3423436B1
(en)
|
2016-03-03 |
2020-09-16 |
Boehringer Ingelheim International GmbH |
Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors
|
|
ES2844926T3
(es)
|
2016-05-12 |
2021-07-23 |
Boehringer Ingelheim Int |
Derivados de piridinilo, composiciones farmacéuticas y usos de los mismos como inhibidores de AOC3
|
|
WO2018027892A1
(en)
|
2016-08-12 |
2018-02-15 |
Eli Lilly And Company |
Amino pyrimidine ssao inhibitors
|
|
US11168069B2
(en)
|
2017-02-07 |
2021-11-09 |
Oblique Therapeutics Ab |
Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
|
WO2018148856A1
(en)
*
|
2017-02-14 |
2018-08-23 |
Eli Lilly And Company |
Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
|
|
US20200087248A1
(en)
|
2017-04-28 |
2020-03-19 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Fluoroallylamine Derivative And Use Thereof
|
|
AU2018287777B2
(en)
|
2017-06-20 |
2020-05-21 |
Shandong Danhong Pharmaceutical Co., Ltd. |
SSAO inhibitor
|
|
CN109251166B
(zh)
|
2017-07-13 |
2021-11-05 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
WO2019024924A1
(zh)
|
2017-08-04 |
2019-02-07 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
CN109810041B
(zh)
|
2017-11-21 |
2023-08-15 |
药捷安康(南京)科技股份有限公司 |
卤代烯丙基胺类ssao/vap-1抑制剂及其应用
|
|
US20210113561A1
(en)
|
2018-04-17 |
2021-04-22 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
DK3873600T5
(da)
|
2018-10-29 |
2024-03-18 |
Boehringer Ingelheim Int |
Pyridinylsulfonamidderivater, farmaceutiske sammensætninger og anvendelser deraf
|
|
US12213970B2
(en)
|
2018-10-29 |
2025-02-04 |
Boehringer Ingelheim International Gmbh |
Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
|